Pureos Bioventures — 2020 Investments

2 investments dated 2020 · listed companies and verified rows first · show all

Eyevensyseyevensys.comSeries B · Jan 2020 · $30M

HealthtechParis

Ronald Buggage(Executive Officer)Thierry Bordet(Executive Officer)Francine Behar Cohen(Executive Officer, Promoter)Patricia Zilliox(Executive Officer, Director, Promoter)

Co-investorsKarista Pontifax Venture Capital

Imcheckimchecktherapeutics.com inSeries B · Sep 2020 · $7Macquired by Clementia

ImCheck Therapeutics develops next-generation immunotherapeutic antibodies targeting the butyrophilin (BTN) and BTN-like (BTNL) superfamily of checkpoint molecules for immune system modulation.

BiotechHealthtech

Co-investorsAgent Capital Andera Partners Kurma Partners Pfizer Venture Investments Alexandria Bpifrance +4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.